PolyPid Announces Positive Results On Trial With Open Bone Fractures Treatment

PolyPid Ltd., an Israeli biotechnology company, announced today positive preliminary results of a first-in-man clinical trial with BonyPid. In the study, BonyPid demonstrated a clear, positive signal of effect in bone recovery processes, on bones with contaminated open fractures.